Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis bcl 2 family'

Search results for: 'research area apoptosis bcl 2 family'

Items 21-30 of 167

Page
per page
  1. 2-Deoxy-D-glucose
    B1027 2-Deoxy-D-glucose
     1 Citation
    Summary: Glycolysis inhibitor
      ≥105 mg/mL
  2. 2-Hydroxypropyl-β-cyclodextrin
    B6413 2-Hydroxypropyl-β-cyclodextrin
    Summary: A cyclic oligosaccharide widely used to improve the aqueous solubility of a variety of compounds
  3. DL-threo-2-methylisocitrate sodium
    B1310 DL-threo-2-methylisocitrate sodium
    Summary: Substrate of isocitrate lyase 1(ICL1)
      Soluble in DMSO
  4. S-(2-aminoethyl) Isothiourea (dihydrobromide)
    C5723 S-(2-aminoethyl) Isothiourea (dihydrobromide)
    Summary: non-selective inhibitor of all NOS isoforms
      ≤10 mg/mL
  5. Cyclophosphamide monohydrate
    A4232 Cyclophosphamide monohydrate
    Summary: alkylating, cytotoxic agent,antitumor activity
      ≥13.95 mg/mL
  6. 4E1RCat
    B3697 4E1RCat
    Target: eIF4F
    Summary: Dual inhibitor of eIF4E:eIF4G and eIF4E:4E-BP1 interaction
      ≥23.85 mg/mL
  7. Monobenzone
    A8478 Monobenzone
    Summary: Skin depigmenting agent
  8. ACES
    C6746 ACES
      Insoluble in DMSO; insoluble in EtOH; ≥17.4 mg/mL
  9. Ro 26-4550 trifluoroacetate
    B5176 Ro 26-4550 trifluoroacetate
    Summary: reversible inhibitor of interleukin-2 (IL-2) binding to its receptor
      <28.03 mg/mL
  10. Thalidomide-4-OH
    C6597 Thalidomide-4-OH
      ≥51.2 mg/mL

Items 21-30 of 167

Page
per page
Shop By
Now Shopping by
  1. Category Others Remove This Item
Clear All
Shopping Options
Category
  1. Actin 2item
  2. Adenylate cyclase 2item
  3. AhR 3item
  4. Aldose reductase 1 item
  5. Antioxidants 1 item
  6. Caged Compounds 1 item
  7. CaM kinase II 2item
  8. Cell Adhesion Molecules 1 item
  9. Ceramidases 2item
  10. COMT 1 item
  11. Cytokine 1 item
  12. DNA Stain 1 item
  13. ES-FLI1/RHA 1 item
  14. Fluorescent Probes 2item
  15. FXR 1 item
  16. Glycosylases 1 item
  17. Guanylyl Cyclase 1 item
  18. Gutathione S-transferase 1 item
  19. Hexokinase 1 item
  20. Hydroxylases 2item
  21. IL Receptor 1 item
  22. Imidazoline Receptors 2item
  23. iNOS 2item
  24. LXR 2item
  25. MDR multidrug resistance 1 item
  26. Menin-MLL 3item
  27. Miscellaneous Compounds 1 item
  28. Myosin 1 item
  29. NADPH Oxidase 1 item
  30. Nampt 3item
  31. Nitric Oxide 1 item
  32. nNOS 2item
  33. Nuclear Receptors 2item
  34. Oxygenases/Oxidases 1 item
  35. PDHK 1 item
  36. RARs 3item
  37. Reagents 6item
  38. Renin 1 item
  39. Retinoid X Receptors 2item
  40. SPHK 2item
  41. Synthases/Synthetases 2item
  42. Thrombopoietin Receptor 1 item
  43. Thymidine phosphorylase 1 item
  44. Transcription Factors 2item
  45. β(1,3)-D-Glucan Synthase 1 item
  46. β-Lactamase 1 item
  47. Others 71item
  48. FAS 1 item
  49. Protein synthesis 2item
  50. Dye Reagents 4item
  51. Quinones 1 item
Specificity
  1. Selective 18item
Target
  1. Farnesoid X receptors (FXRs) 1 item
  2. PDHK 1 item
  3. Renin 1 item
  4. Sphingosine kinases (SphKs) 1 item
  5. Nampt 1 item
  6. eIF4F 1 item
  7. Glutaminases 1 item
  8. NADPH Oxidases 2item
  9. eEF-2 1 item
  10. Antioxidants 1 item
  11. Menin-MLL 2item
  12. STK 1 item
  13. Rev-Erb Receptors 1 item
  14. Aryl hydrocarbon receptors (AHRs) 1 item
  15. DprE 1 item
  16. RHA 1 item
  17. NADH oxidase 1 item
Reported Experiments
  1. Animal Experiments 22item
  2. Cell Experiments 24item
Related Disease
  1. Abscesses And Esophageal Candidiasis 1 item
  2. Acute Disseminated Candidiasis 1 item
  3. Breast Cancer 1 item
  4. Cancer 6item
  5. Candida Peritonitis 1 item
  6. Candidemia 1 item
  7. Fungal Infection 1 item
  8. Glioblastoma 1 item
  9. Glioma 1 item
  10. Leukemia 1 item
  11. Lymphoma 1 item
  12. Tuberculosis 1 item
  13. Type 2 Diabetes 2item